Page last updated: 2024-11-05

thiotepa and Thrombosis

thiotepa has been researched along with Thrombosis in 2 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.

Research Excerpts

ExcerptRelevanceReference
"Arterial thrombosis is also associated with multiagent chemotherapy in patients with breast cancer."1.28Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. ( Korzun, AH; Norton, L; Perloff, M; Rice, MA; Wall, JG; Weiss, RB; Wood, WC, 1989)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferreri, AJ1
Cwynarski, K1
Pulczynski, E1
Ponzoni, M1
Deckert, M1
Politi, LS1
Torri, V1
Fox, CP1
Rosée, PL1
Schorb, E1
Ambrosetti, A1
Roth, A1
Hemmaway, C1
Ferrari, A1
Linton, KM1
Rudà, R1
Binder, M1
Pukrop, T1
Balzarotti, M1
Fabbri, A1
Johnson, P1
Gørløv, JS1
Hess, G1
Panse, J1
Pisani, F1
Tucci, A1
Stilgenbauer, S1
Hertenstein, B1
Keller, U1
Krause, SW1
Levis, A1
Schmoll, HJ1
Cavalli, F1
Finke, J1
Reni, M1
Zucca, E1
Illerhaus, G1
Wall, JG1
Weiss, RB1
Norton, L1
Perloff, M1
Rice, MA1
Korzun, AH1
Wood, WC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Phase II Trial On Primary Chemotherapy With High-Dose Methotrexate And High-Dose Cytarabine With Or Without Thiotepa, And With Or Without Rituximab, Followed By Brain Irradiation Vs. High-Dose Chemotherapy Supported By Autologous Stem Cells Tra[NCT01011920]Phase 2126 participants (Actual)Interventional2009-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for thiotepa and Thrombosis

ArticleYear
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
    The Lancet. Haematology, 2016, Volume: 3, Issue:5

    Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System

2016

Other Studies

1 other study available for thiotepa and Thrombosis

ArticleYear
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study.
    The American journal of medicine, 1989, Volume: 87, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Breast Neoplasms;

1989